Alterity Therapeutics Granted European Patent Titled ‘4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS (FOR THE TREATMENT OF NEUROLOGICAL DISORDERS)’
https://register.epo.org/application?number=EP15865227
Alterity Therapeutics Highlights New Publications On ATH434 In Parkinson’s Disease
Alterity Therapeutics's (NASDAQ: ATHE) data in an animal model of Multiple System Atrophy (MSA) were published in the Journal of Parkinson's Disease.
56 Biggest Movers From Friday
Gainers
Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share.
33 Stocks Moving In Friday’s Mid-Day Session
Gainers
Marin Software Incorporated (NASDAQ: MRIN) shares climbed 35.9% to $4.6899 after the company announced an integration with Amazon Ads' demand-side platform.
58 Biggest Movers From Yesterday
Gainers
Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs
after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe is no long active.
Mid-Afternoon Market Update: Gold Drops 2%; Berkeley Lights Shares Plummet
Toward the end of trading Thursday, the Dow traded down 0.35% to 36,278.43 while the NASDAQ rose 0.22% to 15,133.94. The S&P also rose 0.14% to 4,707.37.
Mid-Day Market Update: Nasdaq Turns Higher; Vocera Communications Shares Surge
Midway through trading Thursday, the Dow traded down 0.34% to 36,284.59 while the NASDAQ rose 0.18% to 15,127.00. The S&P, however, rose 0.07% to 4,703.93.